NCT06069869

Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial

Individually Randomized Crossover Trial of Multiple Micronutrient Supplementation (MMS) Iron Dosages During Pregnancy in Tanzania

• Status: Active Not Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 156 (estimated)
• Sponsor: George Washington University · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is an individually randomized cross-over trial to assess acceptability, preference, and perceived side effects of MMS formulations with 30 mg, 45 mg and 60 mg of iron.

Conditions

• Pregnancy Related

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Multiple Micronutrient Supplements with 30 mg of elemental iron	MMS with 30 mg iron is the active comparator group. The standard UNIMMAP MMS formulation includes 30 mg of iron which will be taken orally once daily for one month.
DIETARY_SUPPLEMENT	Multiple Micronutrient Supplements with 45 mg of elemental iron	MMS with 45 mg iron is an intervention group. MMS with 45 mg of iron plus standard UNIMMAP formulation for other 14 micronutrients will be taken orally once daily for one month.
DIETARY_SUPPLEMENT	Multiple Micronutrient Supplements with 60 mg of elemental iron	MMS with 60 mg iron is an intervention group. MMS with 60 mg of iron plus standard UNIMMAP formulation for other 14 micronutrients will be taken orally once daily for one month.

Timeline

• Start date: 2025-09-26
• Primary completion: 2026-01-23
• Completion: 2026-04-24
• First posted: 2023-10-06
• Last updated: 2026-02-05

Locations

1 site across 1 country: Tanzania